# The Effect of Erythropoietin at the Time of Reperfusion in Acute Myocardial Infarction

> **NCT00882466** · PHASE4 · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 58 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** human recombinant erythropoietin

## Key facts

- **NCT ID:** NCT00882466
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2009-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00882466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00882466, "The Effect of Erythropoietin at the Time of Reperfusion in Acute Myocardial Infarction". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00882466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*